This article was originally published on ETFTrends.com.
Pharmaceutical stocks and sector-related exchange traded funds have enjoyed a great summer and the rally may continue to have legs. Over the past three months, the PowerShares Dynamic Pharmaceuticals Portfolio (NYSEArca: PJP) gained 11.4%, SPDR Pharmaceuticals ETF (NYSEArca: XPH) increased 18.0% and iShares U.S. Pharmaceuticals ETF (NYSEArca: IHE) advanced 12.8%. Meanwhile, the broader iShares Nasdaq [...]
Continue Reading Below